Connect with us

Published

on

The proliferation of weight-loss drugs like Ozempic is having an unintended side-effect on snack makers — a reduction in sales, according to a report.

Walmart said customers who have been taking the popular meds to slim down are cutting back on high-fat and salty treats because the weight-loss drugs help to suppress appetites.

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” John Furner, the CEO of Walmarts US operation, told Bloomberg.

Walmart, which sells weight-loss drugs at its pharmacies, is able to study changes in sales patterns using anonymized data on shopper populations, according to the outlet.

With those data sets, the Bentonville, Ark.-based can see how many customers are on diabetes-turned-weight-loss drugs like Ozempic, Wegovy, and Mounjaro and compare their shopping habits to those not taking the medications.

Furner said people on weight-loss drugs are purchasing “less units, slightly less calories,” but said that it’s too soon to conclude what effect the meds are having on Walmart’s overall sales.

Representatives for Walmart did not immediately respond to The Post’s request for comment.

One woman who takes Mounjaro said the reduction in appetite has cut her grocery bill by as much as 20%.

I still have a fully stocked kitchen, theres chips and pretzels in there. I dont find it tempting, Carolyn MacBain-Waldo told the Wall Street Journal.

Another Mounjaro user said she doesnt think about food all the time anymore and eats far fewer snacks.

The other day I had a single jelly bean, which is unheard of for me, Karyn Carlton, 47, told The Journal, adding that she also recently ordered a kids meal from a fast-food restaurant and felt satiated.

The drug, which stimulates the body to produce insulin and lowers blood sugar, has historically been used to treat Type 2 diabetes but was popularized after patients discovered their slimming effects, and particularly exploded when it was revealed celebrities like Khloe Kardashian and Chelsea Handler admitted to using it.

Their use has filtered to middle America and is only expected to grow, despite disturbing case studies where the medications paralyzed some users’ stomachs and even burned off one woman’s genitals.

Morgan Stanley estimated that 7% of the US population, or 24 million people, will be taking hunger-suppressing weight-loss drugs by 2035 — cutting their daily calorie consumption by as much as 30%, according to the firm, which surveyed over 300 patients.

For a person on an FDA-recommended 2,000-calorie daily diet, that could mean eliminating a one-ounce bag of salted potato chips, a bottle of soda, and more each day.

“The food, beverage, and restaurant industries could see softer demand, particularly for unhealthier foods and high-fat, sweet, and salty options, said Morgan Stanleys tobacco and packaged food analyst Pamela Kaufman.

Kaufman said major food companies like Conagra Brands, Mondelez, and Campbell Soup could see a 3% hit to their bottom lines by 2035.

Kellogg’s Brands, which is behind popular snack foods like Cheez-Its and Pringles, has reportedly been studying the potential impact popular weight-loss drugs could have on consumer behaviors.

“Like everything that potentially impacts our business, well look at it, study it and, if necessary, mitigate,” Kellogg’s chief Steve Cahillane told Bloomberg.

Cahillane called it “very, very early days” for the drugs, but said the company, which also makes Rice Krispie Treats, was “by no means complacent,” suggesting Kellogg’s would make changes to its products if overweight Americans on weight-loss medications continued limiting their calorie intake.

The Post has sought comment from Kellogg’s.

Despite being “early days,” US sales for GLP-1-containing drugs have experienced a whopping 300% increase in prescription volume from 2020 to 2022, according to Trilliant Health.

Of those prescriptions, Ozempic was the most-prescribed GLP-1, and national spending on semaglutide — the peptide name for Ozempic and Wegovy — now exceeds $10 billion, Trilliant Health said.

Continue Reading

Sports

Brayden Schenn joins brother with 1,000th game

Published

on

By

Brayden Schenn joins brother with 1,000th game

WASHINGTON — Brayden Schenn played his 1,000th regular-season NHL game when he and the St. Louis Blues beat the Washington Capitals 5-2 on Thursday night.

Older brother Luke played his 1,000th game Oct. 17 with the Nashville Predators. The Schenns are the eighth set of brothers to each reach that milestone and the first to do so in the same season.

“I’ve always said you don’t get there without the help of tons of people,” Brayden said after his team’s morning skate. “Family being one and coaches and players and teammates and people in the organization. Obviously, you have to embrace the day-to-day grind of the ups and downs and just how hard this league is, but, yeah, pretty special that we have best buddies that push each other every day and get to do it in the same year.”

Blues players celebrated the occasion with Schenn shirts and hats with the captain’s No. 10 on them. Father Jeff gave a pregame speech in the locker room after coach Jim Montgomery said, “Schenner and his bro both getting 1,000 games in the same season is a tribute to the great family raised by Jeff and his wife.”

Jeff Schenn said Brayden was his favorite player on the Blues and tied for his favorite overall, of course, with Luke.

“Honored and privileged and very proud to be part of the big day and the big journey that goes along with it,” their dad said. “You see the hard work and the dedication and the bumps and the bruises and everything you guys put into it. … Just so excited and happy to be here and awful proud of him.”

Montgomery said after the win that Jeff Schenn looked very comfortable speaking in front of the group.

“Jeff and his wife, Brayden’s parents, they raised four great kids and two have played 1,000 games in the NHL,” Montgomery said. “His message was well-received, and you could tell by our start that we wanted to play for our captain.”

Dylan Holloway, who scored twice, said because it was Schenn’s 1,000th game, the Blues “wanted this one bad.”

The Capitals acknowledged the milestone with a message on arena videoboards and an announcement during the first period.

Brayden getting to 1,000 comes amid talk ahead of the March 7 trade deadline that teams are interested in acquiring both of them in separate moves. The Blues are on the fringe of the playoff race in the Western Conference, while the Predators are far out of contention.

“The times I’ve gotten traded, I didn’t expect to get traded, so you really never know,” Brayden said, adding he has loved his time with St. Louis. “It’s a business and that just comes with the flows of kind of where we’re positioned, five points out of the playoffs. But it’s the trade deadline, so some people make rumors. … You just take it a day at a time and just focus on your game and play.”

Brayden, 33, has three years left on his contract at an annual salary cap hit of $6.5 million. Luke, 35, has one more season left after this one at $2.75 million.

The Schenn brothers have played together in the NHL before, spending 3½ seasons with the Philadelphia Flyers from 2013 to 2015. Brayden won the Stanley Cup with the Blues in 2019, then Luke back to back with the Tampa Bay Lightning in 2020 and 2021.

Continue Reading

Sports

Pens’ Bunting out indefinitely after appendectomy

Published

on

By

Pens' Bunting out indefinitely after appendectomy

Pittsburgh Penguins forward Michael Bunting is out indefinitely after undergoing surgery to remove his appendix.

“He’ll be out here for the next little while,” Penguins coach Mike Sullivan said Thursday. “I don’t know the time frame at this point, but that’s that.”

Bunting notched an assist in Pittsburgh’s 6-1 setback to the Philadelphia Flyers on Tuesday. He has 29 points (14 goals, 15 assists) and a minus-18 rating in 58 games this season.

Bunting, 29, has totaled 210 points (90 goals, 120 assists) and a plus-10 rating in 326 career games with the Arizona Coyotes, Toronto Maple Leafs, Carolina Hurricanes and Penguins.

Continue Reading

Sports

Bruins F Frederic (lower body) week-to-week

Published

on

By

Bruins F Frederic (lower body) week-to-week

Boston Bruins forward Trent Frederic is considered week-to-week with a lower-body injury, the team announced.

Frederic sustained the injury during the Bruins’ 5-4 overtime loss to the Toronto Maple Leafs on Tuesday. The timing of the injury is significant for Frederic, who is considered an attractive candidate to be shopped ahead of the NHL trade deadline on March 7.

A pending unrestricted free agent, Frederic has 15 points (eight goals, seven assists) and a minus-14 rating in 57 games this season.

Those totals are a far cry from his career season in 2023-24, when he totaled 40 points (18 goals, 22 assists) and a plus-9 rating in 82 games.

Frederic, 27, has totaled 109 points (55 goals, 54 assists) and a plus-20 rating in 337 career games since being selected by the Bruins with the 29th overall pick of the 2016 NHL Draft.

Continue Reading

Trending